Sleep apnea is a condition in which repeated interruptions in breathing occur during sleep, causing intermittent low oxygen levels and fragmented rest. Factors such as excess weight, structural differences in the airway, and certain neurological conditions can increase susceptibility. Symptoms often include loud snoring, excessive daytime sleepiness, morning headaches, and difficulty concentrating. Proper evaluation for sleep apnea therapy involves overnight sleep studies to assess breathing patterns, oxygen saturation, and sleep stages. Early diagnosis is essential because untreated sleep apnea can increase the risk of heart disease, stroke, diabetes, and accidents caused by fatigue. Identifying individual risk factors allows clinicians to tailor treatment approaches effectively and improve both immediate symptoms and long-term health outcomes.
Management of sleep apnea focuses on keeping the airway open during sleep and improving overall quality of life. Continuous positive airway pressure (CPAP) devices are the most common treatment for moderate to severe cases, while oral appliances may help those with milder forms by repositioning the jaw or tongue. Lifestyle interventions, including weight reduction, avoidance of alcohol or sedatives before bedtime, and consistent sleep routines, support the effectiveness of therapy. In select patients, surgical procedures may be necessary to remove or restructure tissue that obstructs airflow. Ongoing monitoring, adherence support, and collaboration between sleep specialists, pulmonologists, and dentists help optimize therapy outcomes. Comprehensive management ensures better oxygenation, reduces cardiovascular risk, and enhances daily functioning for individuals affected by sleep apnea.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation